CompletedNot Applicable

The Effect of Perineal Massage in Childbirth

Turkey (Türkiye)284 participantsStarted 2010-01

Plain-language summary

Objective To examine the effects of perineal massage applied during the action of birth on the frequency of episiotomy procedures, perineal tearing and the duration of the second stage of birth. Methods The present study was a randomized controlled experimental. Women (284 women) were informed on the study and provided their written consent. 10-minute perineal massage with glycerine was applied to the women in the test group for 4 times during the first stage and 1 time in the second stage of birth. The women in the control group received the routine care procedure at the clinic. Results According to the study findings, 31% of the women in the test group and 69.7% of the women in the control group were made subject to episiotomy (p\<0.05). In the test and control group 9.2%, 2.4% of the women developed spontaneous perineal laceration (p\>0.05). The average duration of the action of birth was 25.33 minutes in the test group and 28.18 minutes in the control group (p\<0.05). Conclusion The study results indicate that perineal massage applied during the action of birth decreased the rate of episiotomy procedure and shortened the duration of the second stage of birth.

Who can participate

Age range

19 Years – 49 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * With no pregnancy-related complications diagnosed during pregnancy, * No definitive indication for C-section, * Satisfying the pregnancy week in terms of the fetal dimensions, * At the 37th-42nd gestation week, * Applying to have her first or second birth, * With no systemic condition, * With head presentation, * At the latent phase of the first stage of birth with a dilatation under 4 cm and effacement below 50%, * That have provided written consent specifying their voluntariness in participating in the study. Exclusion Criteria: * With pregnancy-related complications diagnosed during pregnancy, * Definitive indication for C-section, * No satisfying the pregnancy week in terms of the fetal dimensions, * At the \<37th- \>42nd gestation week, * With systemic condition, * With no head presentation, * At the latent phase of the first stage of birth with a dilatation above 4 cm * No have provided written consent specifying their voluntariness in participating in the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Episiotomy procedures

Timeframe: until completed the second stage of labour, about from 30 min to 24 h

Trial details

NCT IDNCT02201615

SponsorCumhuriyet University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-05

View on ClinicalTrials.gov More Obstetric Labor Complications trials